Monday, September 08, 2008 (New Delhi) Aurobindo Pharma rose 0.95% to Rs 319.05 at 11:52 IST on BSE, after the company said it has secured tentative approval from US Food & Drug Administration to manufacture and market Abacavir Sulphate/Lamivudine tablets. The company made this announcement during trading hours today, 8 September 2008. Meanwhile, the BSE Sensex was up 552.67 points, or 3.82%, to 15,036.50. The...
[read full story]